.png){kind=logo}
CHANGE BEHAVIOR.
DRIVE GROWTH.
We help pharma and life science organizations understand and influence real-world HCP, patient, and stakeholder decisions — from launch strategy to field force effectiveness.
50+
PHARMA BRANDS
20+
THERAPEUTIC AREAS
6 of 10
TOP GLOBAL PHARMA
20+
SMALL-MID PHARMA
OUR FOCUS
Behavioral challenges are pervasive in healthcare
HCPs and patients routinely misunderstand product value, disease processes, and treatment tradeoffs — and even when informed, they often fail to act. We use behavioral science to solve the hardest problems in pharma: not just what people know, but why they do what they do, and how to change it.
CAPABILITY CLUSTERS
Full-service support across the pharma value chain
We support cross-functional teams from insight to execution
We reveal the beliefs, mental models, and cognitive shortcuts blocking adoption — and design evidence plans that close those gaps, not just increase knowledge.
-
Evidence Generation
-
Behavioral Medical Education
-
KOL & KEE Engagement Strategy
OUR FRAMEWORK
We solve the Misperceptions & Inactions that block better decisions and behavior
Behavioral challenges in healthcare almost always come down to two problems: people believe the wrong things (misperceptions) and they fail to act on what they know (inactions). Both are predictable, diagnosable, and correctable — when you know where to look.
The challenge is no longer just understanding customers. It's understanding how everyone is thinking in an age of AI-amplified noise — where misperceptions spread faster, and inaction is reinforced by information overload.
Health Care Providers
-
Misperceive treatment risks relative to familiar standards
-
Struggle navigating uncertainty and novel therapy tradeoffs
-
Default to status quo under cognitive and workflow load
-
Actions constrained by local clinical context and norms
Patients
-
Misperceive disease progression and side-effect probabilities
-
Decisions shaped by identity-based beliefs, not evidence
-
Habits undermine intentions and long-term adherence
-
Overweight present costs versus future benefits
MEASUREABLE IMPACT
Behavioral science produces measurable results
Across engagements in pharma and life sciences, behavioral science interventions consistently outperform conventional approaches on the metrics that matter
>4x
1
Message retention
Behaviorally-designed communications produce significantly higher retention of key clinical claims.
>2x
2
Customer actions initiated
Structuring choices using behavioral principles more than doubles action initiation rates.
>4x
3
Information requests
Temporal framing and goal-anchoring drive significant increase in proactive information seeking.
>2x
2
Lead conversion
Behavioral approaches to sales conversations measurably improve conversion across HCP segments.
CLIENT PERSPECTIVES
What clients say about working with Behavioralize
They didn't just provide insights — they rolled up their sleeves and delivered actionable recommendations that shaped our strategy, research design, and customer engagement approach.
- Senior Research Lead
Your insights were remarkably deep and specific. They challenged what we knew and have led us to change our launch strategy. The value that the team got out of this project was immeasurable.
- Global Commercial Insights Manager
I liked the iterative nature of the process and the regular, collaborative sessions. Unlike other vendors which often seem offended with thoughts from the client, I value that our work is a partnership.
- Global Team Lead, Medical Strategy
Behavioralize's deep expertise in behavioral science was invaluable in helping us pinpoint the biases influencing our therapeutic area. Their insights sharpened our strategy, ensuring we focused on behavior changes we could truly impact.
- Marketing Director
AI-ENHANCED REESEARCH
Our pharma research is delivered through a redesigned, AI-enhanced process. Proprietary tools — Insights Miner, Deep Discovery, and Cross-Project Pattern Detector — operate alongside our behavioral scientists at every stage, from question design through ongoing strategic dialogue. The result: deeper insight, faster.
Citations
1. Ratner, R. and Riis, J. (2014). Communicating science-based recommendations with memorable and actionable guidelines. PNAS, 11(4), 1364-13641.
2. Putnam-Farr, E. and Riis, J. (2016). "Yes/No/Not Right Now": Yes/No Response Format Can Increase Response Rates Even in Non-Forced-Choice Settings. Journal of Marketing Research, 53(3), 424-432.
3. Dai, H., Milkman, K., & Riis, J. (2015). Put Your Imperfections Behind You: Temporal Landmarks Spur Goal Initiation When They Signal New Beginnings. Psychological Science, 26(12), 1927-1936.